Skip to main content
. 2022 Aug 30;14(17):4208. doi: 10.3390/cancers14174208

Figure 1.

Figure 1

Molecular structures of OXi6196 and phosphate prodrug OXi6197, as well as related molecules exhibiting vascular disrupting activity. Exposure of prodrug OXi6197 to alkaline phosphatase leads to rapid release of OXi6196 [27].